Register study on a of anti-infectives concentrations in clinical routine

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039017

Enrollment

1500

Registered

2026-01-16

Start date

2026-01-06

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with infectious diseases who are being treated with anti-infective agents.

Interventions

Group 1: This study aims to create a structured, prospective registry to investigate whether and when defined target ranges are achieved in patients undergoing therapeutic drug monitoring (TDM) of ant

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with routine TDM of anti-infective

Exclusion criteria

Exclusion criteria: Routine TDM of drugs that are not part of ATC class J01-J05

Design outcomes

Primary

Measure	Time frame
What proportion of patients measured in routine TDM are within the defined effective target range after the first dose recommendation? The data is collected as part of routine clinical practice.	—

Secondary

Measure	Time frame
Patient-related influencing factors (such as underlying diseases, laboratory parameters) and procedural influencing factors (such as extracorporeal procedures) on anti-infective concentrations	—

Countries

Germany

Contacts

Public ContactBenedict Morath

Universitätsklinikum Heidelberg, Krankenhausapotheke

benedict.morath@med.uni-heidelberg.de062215638118

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026